Risk factor
Limited default risk
Profitability factor
Very strong margins and returns
About
Synektik Spólka Akcyjna, founded in 2001 and headquartered in Warsaw, Poland, operates as a comprehensive provider of products, services, and information technology solutions within the Polish market. The company focuses its offerings on the fields of surgery, diagnostic imaging, and nuclear medicine. Its core business activities include the distribution of medical equipment utilized in diagnostics, therapy, and nuclear medicine, alongside the creation of specialized IT solutions for radiology. Synektik also manufactures and supplies radiopharmaceutical products crucial for cancer diagnostics. In addition to these, it maintains a research laboratory dedicated to advancing diagnostic imaging systems and runs a service center for medical apparatus. The company further extends its services to include maintenance for medical equipment and the execution of essential acceptance and specialist tests.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, reasona
Target Price
The average target price of SNT.WA is 360 and suggests 6.74% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati